Hims & Hers Health stock tanked Friday after a U.S. regulator said popular weight-loss and diabetes drugs were no longer in shortage. The move could lessen demand for the copycat version that Hims & ...
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...